Azora Therapeutics Inc. – Filings and Transcripts

NASDAQ: AZR
Share price (11/6/26): $4.00
Market cap (11/6/26): $10.5 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2 2026 – amended

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Shelf registration – amended

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Ownership Filter

Coastlands Capital LP

Coastlands Capital LP

News Filter

Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Adial Pharmaceuticals, Inc. Unaudited Pro Forma Condensed Financial Information

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness